Accelerator

Siemens Technology Accelerator

The Siemens Technology Accelerator (STA) is a unique corporate accelerator program run by Siemens AG since 2001, aimed at spinning out non-core technologies from Siemens’ R&D into independent startups. Based in Munich, STA essentially identifies promising internal innovations (often developed at Siemens Corporate Technology labs) that don’t fit Siemens’ core business, and forms new ventures around them.

Read full profile

STA provides seed funding, co-founding management, and access to Siemens’ infrastructure to these ventures, effectively acting as a venture builder. Over its history, the Siemens Technology Accelerator has spun out more than 12 companies across sectors like energy, industrial automation, healthcare, and materials. Notable spin-offs include MetisMotion (advanced actuators), Magazino (warehouse robotics – which STA helped early on), and Epiqo (a digital twin software).

One high-profile case is Rethink Robotics GmbH: in 2020, STA helped relaunch assets of Rethink Robotics (the US cobot pioneer) in a joint venture, integrating it with Siemens technology. The typical STA project starts with identifying a tech with market potential. STA then recruits external entrepreneurs or Siemens intrapreneurs to lead the startup, develops a business plan, secures intellectual property rights (license or assign IP from Siemens to the newco), and provides initial funding (often low millions of euros).

Siemens often remains a minority shareholder and provides pilot customers or manufacturing help. The time from project inception to an independent company launch is around 18–24 months. STA’s model addresses a common big-corporate problem: great inventions that don’t make it to market.

By essentially incubating startups from within, Siemens both creates value from dormant IP and fosters innovation culture. Many STA spin-outs go on to raise venture capital or get acquired. For example, Ionity (an EV charging network) was seeded by Siemens’ STA and later became a major joint venture with automakers.

The Siemens Technology Accelerator operates with a small specialized team and has won awards for corporate venturing. It serves as a best-practice example of how large industrial firms can proactively spin off new ventures rather than let R&D sit on a shelf. In essence, STA extends Siemens’ innovation beyond its core by unleashing startups that bring cutting-edge tech (like novel sensors, new materials, etc.) to the broader market.

GermanyMunichEnergyIndustrialHealthcare

Back to directory Visit site

Details

Location

Munich, Germany

Similar entries

Matched by sector and location overlap

Northvolt

Stockholm, Sweden · Startup

Northvolt is a Swedish battery manufacturer founded to build a European supply of sustainable lithium-ion cells. In November 2024, Northvolt AB filed for Chapter 11 protection in the United States to pursue a financial restructuring while seeking strategic solutions for Northvolt North America. On March 12, 2025, the company filed for bankruptcy in Sweden and a trustee was appointed to oversee the process. Northvolt remains a landmark industrial project for Europe’s battery ambitions, but its current status is restructuring and insolvency rather than a typical growth-stage startup.

StartupIndustrial Scale-upClimateIndustrialEnergy

View profile Visit site

Proxima Fusion

Munich, Germany · Startup

Proxima Fusion is a deep-tech fusion energy company spun out from the Max Planck Institute for Plasma Physics in 2023. It is developing quasi-isodynamic stellarator systems designed for stable, commercial fusion power generation and is targeting a demonstrator pathway toward net-energy performance in the next decade.

StartupGrowthDeep TechCleanTechEnergyClimate Tech

View profile Visit site

Stegra

Stockholm, Sweden · Startup

Stegra (formerly H2 Green Steel) is one of Europe’s most ambitious industrial decarbonization projects, aiming to rebuild steelmaking around renewable energy and green hydrogen. The company is building a fully integrated production campus in Boden, northern Sweden, where abundant hydropower and regional mining supply chains converge. The core innovation is the direct-reduction process: instead of using coal to reduce iron ore, Stegra uses green hydrogen, cutting CO2 emissions by roughly 95% compared with blast-furnace steel. That technical shift is the foundation for a new European supply of low-carbon steel, which is increasingly demanded by automakers, construction firms, and consumer brands. The company rebranded to Stegra in September 2024 to signal that it is more than a steel mill. Its long-term platform vision is to combine renewable power, hydrogen production, and mineral processing into a repeatable template for heavy industry. By 2026, the Boden plant is reported to be more than halfway constructed, with gigascale electrolyzers (supplied by Thyssenkrupp Nucera) being installed and key offtake contracts signed. Customers reportedly include Porsche, Mercedes-Benz, Scania, and IKEA, and more than half of initial output has been pre-sold — a strong indicator that the “green premium” market is real. Stegra’s financing structure is as notable as its technology. Rather than relying solely on venture capital, the company blends project-finance debt with growth equity, totaling more than €6.5 billion in commitments. This makes it one of the largest private industrial raises in Europe and a flagship case for climate infrastructure funding. Its origins are tied to Vargas Holding, a Swedish venture-builder that also co-founded Northvolt and Polarium, acting as an institutional co-founder rather than a conventional accelerator. Early support from EIT InnoEnergy helped validate the project at the EU level. Stegra’s investor roster reflects its strategic importance: Altor Equity Partners, GIC, Just Climate, Temasek, and Porsche SE are among its backers. In 2026, Stegra represents the “Northvolt effect” done right: a proof that Europe can re-industrialize around clean energy and keep advanced manufacturing on the continent. If it succeeds, it will be a template for decarbonizing other hard-to-abate sectors, from cement to fertilizers, and a cornerstone of Europe’s green-industry competitiveness.

StartupGrowthClimateIndustrialEnergy

View profile Visit site

1KOMMA5°

Hamburg, Germany · Startup

1KOMMA5° (named for the 1.5°C climate target) is one of Europe’s fastest-scaling energy transition companies, reaching unicorn status in roughly 21 months. Based in Hamburg, the firm tackles the “last mile” of decarbonization by combining a roll-up acquisition strategy with a software-defined energy platform. Instead of only selling solar panels, 1KOMMA5° acquires local installer businesses across Europe and digitizes them to deliver end-to-end home electrification — solar, batteries, heat pumps, and EV chargers — with consistent quality and financing. The company’s differentiator is Heartbeat, a proprietary energy management system that turns these assets into a virtual power plant. Heartbeat orchestrates when batteries charge or discharge based on real-time spot prices and grid conditions, allowing households to capture savings from dynamic tariffs and to export power during peak demand. In 2025, the system expanded to automated trading of household energy, making “free” electricity periods during windy or sunny hours a tangible consumer benefit. This blending of hardware deployment and energy-software automation allows 1KOMMA5° to capture margin both on installation and on recurring software and energy services. Founder Philipp Schroder (former Tesla country director and Sonnen executive) used his industry network to skip early accelerators, and the company instead embedded itself in the Hamburg Startup City ecosystem. Its acquisition engine is relentless: by buying regional market leaders, it locks in the most scarce resource in the sector — skilled installers — while rapidly expanding geographic reach. By early 2026, 1KOMMA5° had expanded beyond DACH into the Nordics, Spain, and Australia, positioning itself for a cross-continental footprint ahead of a public listing. The company has signaled an IPO-readiness push, backed by record turnover reported for 2024 and an expansion into branded hardware components to increase margin and supply-chain resilience. Its investor base blends strategic and growth capital: Porsche Ventures provided early backing, G2VP brought Silicon Valley cleantech expertise, Eurazeo and eCapital added European growth capital, and Norrsken VC underscored the impact thesis. In 2026, 1KOMMA5° is a case study in how Europe can scale climate tech through operational execution rather than pure technology — a disciplined roll-up with a software heart that turns millions of households into coordinated energy assets.

StartupGrowthCleanTechEnergyIoT

View profile Visit site

AgeVolt

Bratislava, Slovakia · Startup

AgeVolt offers a digital ecosystem for EV charging that integrates with building energy management to prevent overloads and blackouts. Its platform optimizes charging schedules, manages access, and supports payments across fleets and commercial properties. The company is building a network model described as a “booking.com for private chargers,” unlocking underused charging infrastructure. By 2026, AgeVolt is a notable Slovak player in smart charging.

StartupGrowthEV ChargingEnergySoftware

View profile Visit site

Bioptimus

Paris, France · Startup

Bioptimus is the self-proclaimed "Mistral of Biology," spun out in early 2024 by a team of alumni from Google DeepMind and Owkin, including CEO Jean-Philippe Vert. The company is building what it calls the first universal foundation model for biology. Where large language models were trained on text to learn human language, Bioptimus trains on biological data—DNA sequences, protein structures, cellular imagery, and clinical phenotypes—to infer the underlying rules of life. The ambition is not just better predictions but a unified biological reasoning layer that can simulate outcomes before expensive lab work happens. By 2026, Bioptimus has moved from a research thesis to early commercial traction. After a $41M Series A in 2025, the company released its first commercial model that can predict how a specific molecule will interact with a human cell with unusually high accuracy. This enables in-silico screening that reduces wet-lab costs and improves hit rates for drug discovery. French pharma leaders such as Sanofi have begun using these models to prioritize compounds and compress early-stage discovery timelines. The product value is immediate: fewer failed experiments, faster candidate selection, and deeper mechanistic insight. Bioptimus' roadmap focuses on "multi-scale biology," connecting the micro level (genomics and proteomics) to the macro level (patient outcomes and clinical data). Rather than being limited to protein folding, the models aim to bridge across data modalities so a genetic mutation can be linked to disease pathways, tissue behavior, and potential therapeutic interventions. This requires data breadth and regulatory trust, and Bioptimus is building a defensive moat through European data sovereignty. It leverages partnerships with European research hospitals and biobanks to access high-quality patient data that is difficult for US competitors to acquire under GDPR constraints. That compliance burden becomes a competitive advantage: safer access, better provenance, and stronger alignment with European health data governance. The company remains deeply embedded in the Paris ecosystem. It was incubated inside Owkin before spinning out, maintains a presence around Station F, and benefits from the cross-pollination between French AI and biotech communities. Its investor base reflects that positioning: Sofinnova Partners, Bpifrance, Cathay Innovation, Xavier Niel, and Frst provide a blend of life-science expertise, sovereign capital, and deep-tech conviction. In 2026, Bioptimus is the clearest European bet that foundation models can unlock biology at scale—and a contender to become the default AI layer for drug discovery in Europe.

Siemens Technology Accelerator

Details

Similar entries

Northvolt

Proxima Fusion

Stegra

1KOMMA5°

AgeVolt

Bioptimus

Comments